Screener
Charles River Laboratories CRL Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The source filing: Charles River Laboratories’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 9:21 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001100682-26-000118
| Line item | June 27, 2026 | December 27, 2025 |
|---|---|---|
| Redeemable noncontrolling interests | 42,537 | 41,263 |
| Equity: | ||
| Preferred stock, $0.01 par value; 20,000 shares authorized; no shares issued and outstanding | — | — |
| Common stock, $0.01 par value; 120,000 shares authorized; 49,550 shares issued and 47,728 shares outstanding as of June 27, 2026, and 49,217 shares issued and outstanding as of December 27, 2025 | 496 | 492 |
| Additional paid-in capital | 1,986,023 | 1,947,301 |
| Retained earnings | 1,372,295 | 1,388,620 |
| Treasury stock, at cost, 1,822 and zero shares, as of June 27, 2026 and December 27, 2025, respectively | (323,189) | — |
| Accumulated other comprehensive loss | (195,989) | (171,783) |
Item 1. Financial Statements
FAQ
- What is Charles River Laboratories's common stock?
- Charles River Laboratories (CRL) reported common stock of 120M in Q2 2026.
- How has Charles River Laboratories's common stock changed year-over-year?
- Charles River Laboratories's common stock decreased by 0.0% year-over-year, from 120M to 120M.
- What is the long-term trend for Charles River Laboratories's common stock?
- Over 5 years (2020 to 2025), Charles River Laboratories's common stock has grown at a 199.5% compound annual growth rate (CAGR), from 498K to 120M.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).
Ask your AI about Charles River Laboratories's common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude